Cobblestone Capital Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.05M | Sell |
41,148
-2,505
| -6% | -$61.8K | 0.05% | 136 |
|
|
2025
Q2 | $1.06M | Buy |
43,653
+3,552
| +9% | +$82.8K | 0.05% | 132 |
|
|
2025
Q1 | $1.02M | Sell |
40,101
-149
| -0.4% | -$3.9K | 0.06% | 137 |
|
|
2024
Q4 | $1.07M | Sell |
40,250
-111
| -0.3% | -$3.01K | 0.06% | 131 |
|
|
2024
Q3 | $1.17M | Buy |
40,361
+52
| +0.1% | +$1.52K | 0.07% | 123 |
|
|
2024
Q2 | $1.13M | Buy |
40,309
+5
| +0% | +$138 | 0.07% | 120 |
|
|
2024
Q1 | $1.12M | Sell |
40,304
-2,737
| -6% | -$75.9K | 0.07% | 116 |
|
|
2023
Q4 | $1.24M | Sell |
43,041
-13,896
| -24% | -$420K | 0.08% | 109 |
|
|
2023
Q3 | $1.89M | Sell |
56,937
-3,339
| -6% | -$118K | 0.14% | 72 |
|
|
2023
Q2 | $2.21M | Sell |
60,276
-1,436
| -2% | -$55.9K | 0.16% | 68 |
|
|
2023
Q1 | $2.52M | Buy |
61,712
+671
| +1% | +$29K | 0.19% | 61 |
|
|
2022
Q4 | $3.13M | Sell |
61,041
-2,619
| -4% | -$126K | 0.24% | 55 |
|
|
2022
Q3 | $2.79M | Buy |
63,660
+355
| +0.6% | +$17.3K | 0.23% | 54 |
|
|
2022
Q2 | $3.32M | Buy |
63,305
+3,135
| +5% | +$160K | 0.25% | 51 |
|
|
2022
Q1 | $3.12M | Sell |
60,170
-1,213
| -2% | -$62.9K | 0.21% | 54 |
|
|
2021
Q4 | $3.63M | Buy |
61,383
+1,903
| +3% | +$94.3K | 0.23% | 50 |
|
|
2021
Q3 | $2.56M | Sell |
59,480
-1,865
| -3% | -$82.6K | 0.17% | 61 |
|
|
2021
Q2 | $2.4M | Buy |
61,345
+959
| +2% | +$37.3K | 0.16% | 65 |
|
|
2021
Q1 | $2.19M | Buy |
60,386
+17,211
| +40% | +$611K | 0.16% | 68 |
|
|
2020
Q4 | $1.59M | Buy |
43,175
+1,507
| +4% | +$55.3K | 0.12% | 82 |
|
|
2020
Q3 | $1.45M | Buy |
41,668
+4,190
| +11% | +$147K | 0.13% | 84 |
|
|
2020
Q2 | $1.16M | Buy |
37,478
+444
| +1% | +$15.1K | 0.11% | 92 |
|
|
2020
Q1 | $1.15M | Sell |
37,034
-3,230
| -8% | -$110K | 0.12% | 88 |
|
|
2019
Q4 | $1.5M | Sell |
40,264
-3,150
| -7% | -$112K | 0.14% | 80 |
|
|
2019
Q3 | $1.48M | Buy |
43,414
+3,712
| +9% | +$135K | 0.15% | 77 |
|
|
2019
Q2 | $1.63M | Sell |
39,702
-2,648
| -6% | -$105K | 0.15% | 79 |
|
|
2019
Q1 | $1.71M | Sell |
42,350
-358
| -0.8% | -$14.3K | 0.16% | 71 |
|
|
2018
Q4 | $1.77M | Sell |
42,708
-1,286
| -3% | -$53.4K | 0.18% | 68 |
|
|
2018
Q3 | $1.84M | Sell |
43,994
-1,971
| -4% | -$75.9K | 0.17% | 69 |
|
|
2018
Q2 | $1.58M | Buy |
45,965
+2,885
| +7% | +$98.6K | 0.16% | 69 |
|
|
2018
Q1 | $1.45M | Sell |
43,080
-1,733
| -4% | -$59.6K | 0.15% | 74 |
|
|
2017
Q4 | $1.54M | Sell |
44,813
-575
| -1% | -$19.6K | 0.15% | 76 |
|
|
2017
Q3 | $1.54M | Buy |
45,388
+3,372
| +8% | +$108K | 0.19% | 66 |
|
|
2017
Q2 | $1.34M | Buy |
42,016
+2,037
| +5% | +$64.2K | 0.17% | 69 |
|
|
2017
Q1 | $1.3M | Sell |
39,979
-3,100
| -7% | -$97.7K | 0.17% | 70 |
|
|
2016
Q4 | $1.33M | Sell |
43,079
-1,487
| -3% | -$45.4K | 0.18% | 67 |
|
|
2016
Q3 | $1.43M | Buy |
44,566
+3,902
| +10% | +$130K | 0.2% | 66 |
|
|
2016
Q2 | $1.36M | Sell |
40,664
-543
| -1% | -$17.3K | 0.19% | 66 |
|
|
2016
Q1 | $1.16M | Buy |
41,207
+5,128
| +14% | +$146K | 0.17% | 70 |
|
|
2015
Q4 | $1.1M | Buy |
36,079
+3,899
| +12% | +$123K | 0.17% | 76 |
|
|
2015
Q3 | $959K | Buy |
32,180
+3,799
| +13% | +$122K | 0.15% | 82 |
|
|
2015
Q2 | $903K | Buy |
28,381
+3,014
| +12% | +$98.2K | 0.14% | 92 |
|
|
2015
Q1 | $837K | Sell |
25,367
-1,614
| -6% | -$51.3K | 0.13% | 96 |
|
|
2014
Q4 | $797K | Buy |
26,981
+2,431
| +10% | +$69.7K | 0.14% | 96 |
|
|
2014
Q3 | $689K | Sell |
24,550
-17
| -0.1% | -$477 | 0.13% | 101 |
|
|
2014
Q2 | $692K | Buy |
24,567
+2,672
| +12% | +$76.2K | 0.13% | 102 |
|
|
2014
Q1 | $667K | Buy |
21,895
+13
| +0.1% | +$388 | 0.13% | 105 |
|
|
2013
Q4 | $636K | Buy |
21,882
+296
| +1% | +$8.62K | 0.12% | 107 |
|
|
2013
Q3 | $588K | Sell |
21,586
-1,535
| -7% | -$41.8K | 0.12% | 101 |
|
|
2013
Q2 | $614K | Buy |
+23,121
| New | +$639K | 0.13% | 97 |
|
Other funds holding PFE
Cobblestone Capital Advisors's PFE Position: Q3 2025 in Review
Cobblestone Capital Advisors reduced its Pfizer (PFE) stake by 5.7% in Q3 2025, selling an estimated $61.8K and leaving 41,148 shares worth $1.05M. The position accounts for 0.05% of the portfolio, ranked #136.
Cobblestone Capital Advisors first reported a position in PFE in Q2 2013 and has held it in 50 quarters since. The position peaked at $3.63M in Q4 2021. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.
- Cobblestone Capital Advisors held 41,148 shares of Pfizer worth $1.05M as of Q3 2025.
- Cobblestone Capital Advisors sold 2,505 Pfizer shares in Q3 2025, an estimated $61.8K.
- Pfizer made up 0.05% of Cobblestone Capital Advisors's portfolio in Q3 2025, its #136 holding.
- Cobblestone Capital Advisors first reported a position in Pfizer in Q2 2013 and has held it in 50 quarters since.
- Cobblestone Capital Advisors's Pfizer position peaked at $3.63M in Q4 2021.
- 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.
Based on Cobblestone Capital Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.